Clays are ubiquitous near the Earth’s surface. Medicinal properties of these nontoxic minerals have been intuitively recognized since ancient times. Up till now, clays have been used in pharmaceutical formulations as active agents and excipients. Currently, there is an urgent need to seek advanced, functional materials with low environmental impact. Answering to that trend, clay-biopolymer nanocomposites were synthesized in this thesis and applied in a drug delivery system. In the first part of the thesis, Portuguese clay from a bentonite deposit in Benavila (Portugal) was collected from six sampling sites and characterized. The highest content of clay fraction, approximately 30%, was found in two of the sampling sites. After purification, the smectite-rich samples were analyzed with respect to clay content, mineralogical and chemical composition, physicochemical and mechanical properties. SEM-EDS revealed that the smectite present in the ore is montmorillonite with varying Fe content. This was also indicated by the means of XRD, XRF and FTIR. The Benavila sample, which was richest in smectite, as well as the sodium Wyoming montmorillonite from the Source Clay Repository (SWy-2) were successfully used to synthesize clay-biopolymer nanocomposites. The chosen biopolymers were the plant-extracted polysaccharides – neutral guar gum and its cationic form. The obtained materials were thoroughly characterized by XRD, TGA and NMR, and the intercalated structure was reported. The prepared nanocomposites were loaded with an anti-inflammatory drug ibuprofen and tested in an in-vitro release system. The drug-loaded materials were characterized with XRD, TGA and NMR. A membrane diffusion method was chosen as a dissolution testing strategy and the drug was quantified by UV-Vis spectroscopy. The materials exhibited improved properties as a noticeable reduction of release rate was achieved.